In patients with stomach cancer following five genes were most significantly downregulated: GPX3 (1.65E−19), CLEC3B (5.70E−19), CFD (5.68E−18), GSN (4.5 IE−17), and CCL14 (1.12E−16) (Fig. 4C). This evidence concerns the gene CLEC3B and gastric cancer.